Stereotaxis Inc - Asset Resilience Ratio
Stereotaxis Inc (STXS) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2003–2023)
This chart shows how Stereotaxis Inc's Asset Resilience Ratio has changed over time. Check STXS PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Stereotaxis Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see STXS market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Stereotaxis Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Stereotaxis Inc Industry Peers by Asset Resilience Ratio
Compare Stereotaxis Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOYA CORP. ADR/ 1 O.N.
F:HYB0 |
Medical Instruments & Supplies | 0.37% |
|
STRAUM.HLD.UNSP.ADR/1/10
F:QS50 |
Medical Instruments & Supplies | 0.38% |
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 4.32% |
|
Visco Vision Inc.
TW:6782 |
Medical Instruments & Supplies | 0.98% |
|
Mark Dynamics Indonesia Tbk PT
JK:MARK |
Medical Instruments & Supplies | 6.64% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
Annual Asset Resilience Ratio for Stereotaxis Inc (2003–2023)
The table below shows the annual Asset Resilience Ratio data for Stereotaxis Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.00% | $0.00 | $41.91 Million | -- |
| 2022-12-31 | 37.15% | $19.84 Million | $53.41 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $60.98 Million | -- |
| 2012-12-31 | 3.24% | $1.04 Million | $32.17 Million | -7.73pp |
| 2007-12-31 | 10.97% | $6.63 Million | $60.48 Million | -20.45pp |
| 2006-12-31 | 31.42% | $21.77 Million | $69.29 Million | +16.35pp |
| 2005-12-31 | 15.07% | $5.52 Million | $36.66 Million | -25.30pp |
| 2004-12-31 | 40.37% | $28.74 Million | $71.19 Million | +26.64pp |
| 2003-12-31 | 13.73% | $5.12 Million | $37.32 Million | -- |
About Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires thro… Read more